JPMorgan Chase Bank, N.A.
depositary receipt of JPMorgan Chase Bank, N.A. representing ordinary share of Dr. Reddy’s Laboratories Limited
Information about the Issuer
- Full nameJPMorgan Chase Bank, N.A.
- State of incorporationthe United States of America
Information about the Depositary Receipt
- Trading symbol
- Security kinddepositary receipt
- Security category and typedepositary receipt representing share ordinary share
- ISINUS2561352038
- CFI code, ISO 10962:2015EDSXFR
- CFI code, ISO 10962:2001ESVUFA
- Recognised trading venueNew York Stock Exchange LLC
- Admitted to trading, or retained on the list of qualified investments admitted to trading despite of failure to comply with ITS Rules on admission to tradingNo
Information Disclosure
- DR program website
- Information disclosed on the website of the recognised trading venue
Information about the Issuer of the Underlying Securities
- Full nameDr. Reddy’s Laboratories Limited
- State of incorporationthe Republic of India
- Issuer's website
- Investor relations section of Issuer's website
- Information about the Depositary receipt and issuer of the underlying securities published on the website of the regulatory body, and/or a duly authorized disclosure agency [1]
- Annual reports[2]
Information about the Underlying Securities
- Security kindshare
- Security category and typeshare ordinary share
- Security class-
- ISININE089A01023
- CFI code, ISO 10962:2015ESVUFN
- Par value5
- Par value currencyINR
Trading Instrument Parameters
- Date of admission to trading07.06.2023
- Trading modesMain Trading Mode, Negotiated Transaction Mode, Negotiated repurchase with the Central Counterparty, RFQ Trading Mode
- Instrument groupUS Market Securities
- Lot1
- Price tick0.01
- Price currencyUSD
- Settlement currencyUSD
If necessary switch to the English version of the website and/or search by issuer's full name (refer to "Full name" field in the section "Information about Issuer") and, if applicable, indicate the search period, with regard to the supported time range
Annual reports disclosed after the date of admission to trading on the recognised trading venue, or for the last three years, if admitted to trading earlier than 3 years ago